Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |